Cargando…
RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma
Hepatocellular carcinoma (HCC), one of the most common and lethal cancers worldwide, has a high recurrence rate with current treatment modalities. Identifying biomarkers for early diagnosis and discovering new sufficient molecular targets for the development of targeted therapies are urgently needed...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432270/ https://www.ncbi.nlm.nih.gov/pubmed/28460436 http://dx.doi.org/10.18632/oncotarget.15507 |